ID 14178
Eprint ID
FullText URL
Thumnail 103_791.pdf 574 KB
Title Alternative
Studies on the regulation of eosinophils in bronchial asthma Part 2. Migratory responses of eosinophils from asthmatics
Takahashi, Hisaho
Eosinophil infiltration in lung tissue is one of the characteristic features of bronchial asthma. Such cell infiltration seems to be induced by the eosinophil chemotactic factor (ECF). PAF and IL-5 are potent chemoattractants and activators for eosinophils. To evaluate the reactivity of eosinophils in asthmatics under various conditions, the migratory function of eosinophils to PAF and IL-5 was investigated by the modified Boyden chamber method. Eosinophils of asthmatics were highly purified using a flow cytometric method previously reported. The migratory response of the eosinophils of asthmatics was greater than that of healthy suljects. Eosinophils from atopic asthmatics showed a higher response to PAF than those from non-atopic asthmatics. Eosinophils in the attack stage showed a higher response than those in the non-attack stage. Hypodense eosinophils showed an increased migratory response. The migratory response was correlated to the serum concentration of ECP and blood eosinophil count. These findings suggest that the reactivity of eosinophils is heterogenous and relates to the degree of eosinophilia, and that IL-5 as well as PAF plays an important role in the pathogenesis of bronchial asthma.
Bronchial asthma
Eosinophil migratory response
Platelet-activating factor
Eosinophil heterogeneity
Published Date
Publication Title
Publication Title Alternative
Journal of Okayama Medical Association
Publisher Alternative
Okayama Medical Association
Start Page
End Page
Content Type
Journal Article
Official Url
Related Url
1) Horn BR, Robin ED, Theodore J and van Kessel A : Total eosinophil counts in the management of bronchial asthma. N Engl J Med (1975) 292, 1152-1155.
2) 難波一弘,高橋 清,多田慎也,清水一紀,中藤研一,岡田千春,辻 光明,沖 和彦,木村郁郎,谷崎勝郎:House dust による気管支喘息患者遅発型気道反応の発症機序に関する検討-気管支肺胞洗浄法を中心に-.アレルギー (1988) 37, 67-74.
3) Wardlaw AJ, Moqbel R, Cromwell O and Kay AB : Platelet-activating factor ; a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 78, 1701-1706.
4) Tamura N, Agrawal DK, Sulian FA and Townley RG : Effect of platelet-activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun (1987) 142, 638-644.
5) Wang JW, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ and Montovani A : Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol (1989) 19, 701-705.
6) de Monchy JGR, Postma DS, Kauffman HF, Venge P, Weeke B and Vries K : Pretreatment with inhaled corticosteroids reduces eosinophil chemotaxis of BAL fluid following house dust mite challenge, Proceedings of the International Congress of Allergology and Clinical Immunology, Montreux, Switzerland (1988) pp249.
7) 木村郁郎:遅発型アレルギーの発症機序-細胞反応を中心に;第3回免疫薬理シンポジウム議事録,デー・エム・ベー・ジャパン,東京 (1985) pp23-40.
8) 木村郁郎:気管支肺病変におけるアレルギーとリンパ球.アレルギア (1990) 19, 12-16.
9) 宮川秀文,難波一弘,白石高昌,名部 誠,槇本 晃,佐藤 恭,武田 昌,多田慎也,高橋 清,木村郁郎:重症難治性喘息におけるⅣ型アレルギーの関与について-Candida 抗原によるIL-2 産生能と好中球遊走活性-.アレルギー (1988) 37, 12-18.
10) 河田一郎:気管支喘息の発症機序における好酸球動態に関する研究-第2編カンジダ抗原による末梢血単核球由来好酸球遊走因子について.岡山医誌 (1990) 102, 745-755.
11) 河田一郎:気管支喘息の発症機序における好酸球の動態に関する研究-第1編フローサイトメトリーを用いた好酸球分離法と好酸球遊走因子について.岡山医誌 (1990) 102, 733-743.
12) Tsujimoto M, Adachi H, Kodama S, Tsuruoka N, Yamada Y, Tanaka S, Mita S and Takatsu K : Purification and characterization of recombinant human interleukin 5 expressed in chinese hamster ovary cells. J Biochem (1989) 106, 23-28.
13) 福田 健,沼尾利郎,阿久津郁夫,本島新司,牧野荘平:Ⅰ型アレルギー反応における好酸球遊走活性メディエーターの解析,第5回免疫薬理シンポジウム議事録,デー・エム・ベー・ジャパン,東京 (1987) pp59-72.
14) Schleimer RP, Macglashan DWJr., Peters SP, Pinckard RN, Adkinson NFJr. and Lichtenstein LM : Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis (1986) 133, 614-617.
15) Goetzl EJ, woods JM and Gorman RR : Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and rondom migration by 12-L-hydroxy-5, 8, 10, 14-eicosatetraenoic acid (HETE). J Clin Invest (1977) 59, 170-183.
16) Kay AB, Stechschulte DJ and Austen KF : An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med (1971) 133, 602-619.
17) Bryant DH, Turnbull LW and Kay AB : Eosinophil chemotaxis to an ECF-A tetrapeptide and histamine ; the response in various disease states. Clin Allergy (1977) 7, 219.
18) Kay AB : Studies on eosinophil leukocyte migration. Ⅱ. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol (1970) 7, 723-737.
19) Lachmann PJ, Kay AB and Thompson RA : The chemotactic activity for neutrophil and eosinophil leukocytes of the trimolecular complex of human complement (C567) prepared in free solution by the ‛Reactive lysis’ procedure. Immunology (1970) 19, 895-899.
20) Barnes PJ, Fan Chung K and Page CP : Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol (1988) 81, 919-934.
21) Tamura N, Agrawal DK and Townley RG : LeukotrieneC4 production from human eosinophils in vitro ; Role of eosinophil chemotactic factors on eosinophil activation. J Immunol (1988) 141, 4291-4297.
22) Kloprogge E, de Leeuw AJ, de Monchy JGR and Kauffmann HF : Hypodense eosinophilic granulocytes in normal individuals and patients with asthma. Generation of hypodense cell populations in vitro. J Allergy Clin Immunol (1989) 83, 393-400.
23) Kroegel C, Yukawa T, Dent G, Venge P, Fan Chung K and Barnes PJ : Stimulation of degraulation from human eosinophils by platelet-activating factor. J Immunol (1989) 142, 3518-3526.
24) 須甲松伸:PAF と好酸球.最新医学 (1990) 45, 492-496.
25) Lee TC, Lenihan DJ, Malone B, Roddy LL and Wassermann SI : Incresed biosynthesis of platelet-activating factor in activated eosinophils. J Biol Chem (1984) 259, 5526-5532.
26) Fukuda T and Gleich GJ : Heterogeneity of human eosinophils. J Allergy Clin Immunol (1989) 83, 369-373.
27) Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A and Takatsu K : Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med (1988) 167, 43-56.
28) Chihara J, Plumas J, Gruart V, Tavernier J, Prin L, Capron A and Capron M : Characterization of a receptor for interleukin 5 on human eosinophils ; Variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med (1990) 172, 1347-1351.
29) Gosset P, Prin L, Capron M, Auriault C, Tonnel A-B and Capron A : Presence of factors chemotactic for granulocytes in hypereosinophilic syndorome sera ; relation with alterations in eosinophil migration. Clin Exp Immunol (1986) 65, 654-663.
30) Suko M, Okudaira H, Shida T and Miyamoto T : Eosinophils in asthma, Eosinphils in allergy and clinical immunology, Proceedings of a symposium held at the ⅩⅢ international congress of allergology and clinical immunology, Montreux, Switzerland (1988) pp55-70.
31) Fukuda T, Dunnette SL, Reed CE, Ackerman SJ, Peters MS and Gleich GJ : Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis (1985) 132, 981-985.
32) White CJ, Maxwell CJ and Gallin JI : Changes in the structural and functional properties of human eosinophilia during experimental hookworm infection. J Infect Dis (1986) 154, 778.
33) David JR, Vadas MA, Butterworth AE, Azevedo de Brito, P. Carvalho EM, David RA, Bina JC and Andrade ZA : Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med (1980) 303, 1147-1152.
34) Ding-E Young J, Peterson CGB, Venge P and Cohn ZA : Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature (1986) 32, 613-616.
35) Gleich GJ, Frigas E, Loegering DA, Wasson DL and Steinmuller D : Cytotoxic properties of the esinophil major basic protein. J Immunol (1979) 123, 2925-2927.
36) Henderson WR, Jorg EC and Klibanoff SJ : Binding of eosinophil peroxidase to mast cell granules with retension of peroxidatic activity. J Immunol (1980) 124, 1383-1388.
37) Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ and McKean DJ : Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein, homology with ribonuclease. Proc Natl Acad Sci USA (1986) 83, 3146-3150.
38) Venge P, Dahl R and Peterson CGB : Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. Int Arch Allergy Appl Immun (1988) 87, 306-312.
39) Rothenberg ME, Peterson J, Stevens RL, Silberstein DS, McKenzie DT, Austen KF and Owen WFJr. : IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accerlated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol (1989) 143, 2311-2316.
40) Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K and Sudo T : Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival ; IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 167, 1737-1742.
41) Fujisawa T, Abu-Ghazaleu R, Kita H, Sanderson CJ and Gleich GJ : Regulatory effects of cytokines on eosinophil degranulation. J Immunol (1990) 144, 642-646.
42) Lopez AF, Begley CG, Williamson DJ, Warren DJ, Vadas MA and Sanderson CJ : Murine eosinophil differentiation factor ; an eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med (1986) 163, 1085-1099.
43) Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ and Kay AB : IL-5 enhances the in vitro adhesion of human eosinophils but not neutrophils, in a leucocyte integrin (CD 11/18)-dependent manner. Immunolgy (1990) 71, 258-265.
Copyright Holders
File Version
Sort Key
Eprints Journal Name